Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Condition(s):Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery DiseasesLast Updated:September 28, 2023Recruiting
Condition(s):Angio-Oedema Caused by Angiotensin-Converting-Enzyme InhibitorLast Updated:October 18, 2023Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:November 9, 2022Not yet recruiting
Condition(s):Angioedema Caused by Angiotensin-Converting-Enzyme InhibitorLast Updated:March 27, 2024Terminated
Condition(s):Kidney FailureLast Updated:October 22, 2012Completed
Condition(s):Exercise; Angiotensin-Converting Enzyme InhibitorsLast Updated:November 5, 2020Completed
Condition(s):Angiotensin Converting Enzyme Inhibitor Induced AngioedemaLast Updated:June 8, 2021Completed
Condition(s):COVID-19Last Updated:August 2, 2021Completed
Condition(s):Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United KingdomLast Updated:November 13, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.